Abbvie

79 results

Tablets of Shire’s Adderall. Abbvie is paying about £52.48 per share for Shire. Photo: Bloomberg

US drugmaker AbbVie bought Dublin-based Shire on Friday in a $53 billion-pound deal that will allow it to slash its tax bill by relocating to Britain.(...)

Jacob “Jack” Lew, US treasury secretary.   Mr Lew has urged members of Congress  to pass legislation immediately to stop US companies from shifting their legal addresses overseas

The Obama administration has added its voice to the growing chorus of criticism of US companies shifting their legal addresses overseas, in many cases(...)

Vitamins made by Shire are displayed at a chemist’s in northwest London. European shares rose on Monday, boosted by M&A activity in the pharmaceutical sector. Photo: Reuters

European shares rose on Monday, boosted by M&A activity in the pharmaceutical sector and rallying from near two-month lows after their biggest wee(...)

US drugmaker AbbVie has been forced to retract comments by its chief executive about shareholder support for its bid for Shire after being caught out(...)

AbbVie increased its offer by about 11 per cent to £51.15 a share in cash and stock after meeting with Shire’s top shareholders, the drugmaker said today. Photographer: Simon Dawson/Bloomberg

US pharma group AbbVie made a fourth offer to buy Irish-headquartered rare drug company Shire, raising the price to about £30.1 billion (€38 billion) (...)

Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire . Photographer: JB Reed/Bloomberg News

US drugmaker AbbVie raised its offer for Shire to £51.15 a share on Tuesday, hoping to win over its reluctant target after an earlier offer was rejec(...)

Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire . Photographer: JB Reed/Bloomberg News

Shire, which has spurned a $46 billion takeover offer from US group AbbVie as inadequate, has a new reason to argue it is worth more after a US court (...)

Shire shareholders deserve a higher price than US drugmaker AbbVie is offering, given the company’s growth prospects, Shire’s chief executive officer (...)

Abbvie’s raised outlook came on the same day that Shire issued its own stand-alone growth plan

Biopharmaceutical firm AbbVie, which is trying to buy London-listed peer Shire, on Monday raised its 2014 adjusted earnings forecast, citing strong “b(...)

Founded in 1986 in Britain, Shire conducts most of its business in the United States and has been domiciled in Ireland for tax purposes since 2008. Photograph: JB Reed/Bloomberg News

US drugmaker AbbVie Inc has confirmed today that it had made a bid approach to Shire , which was rejected by the British group’s board. It said talks (...)

  • « First
  • Prev
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next
  • Last »